Journal ArticleOPEN ACCESS

Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma

Leukemia (2020) 34(12) 3413-3419
DOI: 10.1038/s41375-020-1000-0
73Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Lim, J. Q., Huang, D., Tang, T., Tan, D., Laurensia, Y., Peng, R. J., … Lim, S. T. (2020). Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma. Leukemia, 34(12), 3413–3419. https://doi.org/10.1038/s41375-020-1000-0

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free